The RECOVER sUb-study, Which Leverages quaNtitative and Credible Research tOols From Verily, Will providE Assessment measuRes for Depressive Episodes

Hapworth Research Inc., New York

Scranton Medical Institutes, Moosic

Sheppard Pratt Health Systems, Baltimore

Carilion Clinic, Roanoke

Center for Neuropsychiatry and Brain Stimulation (CNBS), Cary

Augusta University, Augusta

APG Research, LLC, Orlando

Nova Psychiatry Inc., Orlando

Advanced Mental Health Care Inc., Royal Palm Beach

Kind Research Group, Boca Raton

Stedman Clinical Trials, Tampa

University of Alabama at Birmingham, Birmingham

Ohio State University, Columbus

Beacon Medical Group Behavioral Health, South Bend

Michigan Clinical Research Institute PC, Ann Arbor

Psychiatric Medicine Associates, LLC, Skokie

AMR-Baber Research, Inc., Naperville

Southern Illinois University School of Medicine, Springfield

PsychCare Consultants Research, St Louis

Alivation Research, LLC, Lincoln

OU-SOCM Dept of Psychiatry, Tulsa

North Pointe Psychiatry, Lewisville

UT Center of Excellence on Mood Disorders, Houston

UT Health Austin, Austin

Keck Hospital of USC, Los Angeles

ATP Clinical Research, Inc., Costa Mesa

SF-Care, Inc., San Rafael

Florida Center for TMS, Saint Augustine

Seattle Neuropsychiatric Treatment Center, Bellevue

Center for Anxiety and Depression, Mercer Island

Psychiatric Care and Research, O'Fallon

University of Pennsylvania Perelman School of Medicine, Philadelphia

Neuropsychiatric Associates, Plc, Woodstock